# The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells

> **NCT00609362** · PHASE2 · COMPLETED · sponsor: **University of Aarhus** · enrollment: 57 (actual)

## Conditions studied

- Change in Bone Mineral Density
- Change in Bone Marrow Fat Content

## Interventions

- **DRUG:** Rosiglitazone
- **DRUG:** Placebo pill

## Key facts

- **NCT ID:** NCT00609362
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2011-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00609362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00609362, "The Effect of Glitazone Treatment on Bone Marrow and Bone Marrow Cells". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00609362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*